Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 5-HT₂C receptor is a subtype of serotonin receptor, part of the 5-HT2 family, and a G protein-coupled receptor (GPCR) primarily coupled to the Gq/G11 protein. It mediates excitatory neurotransmission and is widely distributed in the central nervous system and, to a lesser extent, in peripheral tissues. It plays significant roles in regulating mood, anxiety, feeding behavior, and reproductive behavior. Drugs targeting the 5-HT₂C receptor are used or investigated for obesity, schizophrenia, drug abuse, and migraine. Agonists include endogenous serotonin and ergotamine; ritanserin acts as an inverse agonist. Ligand binding induces characteristic shifts in transmembrane helices that underlie activation or inhibition of signaling pathways.
Agonist or antagonist binding to the 5-HT2C receptor modulates downstream signaling pathways via Gq/G11 protein coupling, influencing neurotransmitter release and neuronal excitability.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin Receptor 5-HT₂C (5-HT2C).